PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1383
https://www.valueinhealthjournal.com/article/S1098-3015(12)03096-3/fulltext
Title : PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03096-3&doi=10.1016/j.jval.2012.08.1383
First page : A444
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 879
Categories :
Tags :
Regions :
ViH Article Tags :